| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |